Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
New study presents a human-relevant stress model for assessing potential therapeutics
Positive volume growth was observed in key therapies such as respiratory (13.2% yoy), anti-neoplastics (12.1% yoy) and cardiac (4.8% yoy) during September 2025
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Deflazacort oral suspension is indicated for treating Duchenne Muscular Dystrophy in patients 5 years of age and older
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
Subscribe To Our Newsletter & Stay Updated
